• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Prognostic value of troponin I in COVID-19 patients

Bioengineer by Bioengineer
May 28, 2021
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Alaa A. Ghaleb and colleagues is published in The Open Cardiovascular Medicine Journal, 2021

IMAGE

Credit: Dr. Alaa A. Ghaleb et al., Bentham Open

Corona Virus Disease (COVID -19) patients primarily appear with respiratory issues and viral pneumonia. The patients may also present cardiovascular issues includes early signs of acute myocardial injury. The researchers from Sohag University, Egypt, found that cardiac troponin I (cTnI) can prove to be a gold-standard biomarker for necrosis and myocardial risk assessment in COVID-19 sufferers.

The researchers aimed to assess the prognostic value of cTnI in COVID-19 sufferers. The study included ninety-two COVID-19 patients admitted in the El Helal Hospital, Sohag, Egypt. The hospital, upon admission, did routine investigations including cTnI, chest Computed Tomography (CT), and Electrocardiogram (ECG). Additionally, the patients admitted to the intensive care unit (ICU) received echocardiography testing. The research found that the cTnI level was elevated in 30 patients admitted to the ICU, of whom 17 died. The researchers conclude that cardiac troponin I levels are a prognostic factor for ICU admission and mortality in COVID-19 patients.

To download and read the Full-text article, please visit: https://benthamopen.com/ABSTRACT/TOCMJ-15-18

###

Media Contact
Faizan ul Haq
[email protected]

Related Journal Article

http://dx.doi.org/10.2174/1874192402115010018

Tags: BiochemistryCardiologyClinical TrialsInfectious/Emerging DiseasesMedicine/HealthPharmaceutical SciencePharmaceutical SciencesPharmaceutical/Combinatorial ChemistryVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

Social Determinants Influence Hormone Therapy in Midlife Women

September 1, 2025

ASIC1a Deficiency Lowers Anxiety in Specific Brain Neurons

September 1, 2025

Valproate and Vitamin E Protect White Matter Integrity

September 1, 2025

Reviving Ovarian Function Post-Chemotherapy: Advances Ahead

September 1, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Do people and monkeys see colors the same way?

    112 shares
    Share 45 Tweet 28

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Effects of Media and Temperature on Methane Production

Two-Phase Hybrid Clustering Enhances HAR Transitional Insights

Social Determinants Influence Hormone Therapy in Midlife Women

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.